Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT00791635

Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer

Conditions: Cervical Carcinoma, Endometrial Carcinoma, Malignant Female Reproductive System Neoplasm, Vaginal Carcinoma, Vulvar Carcinoma

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 79
Sponsor: M.D. Anderson Cancer Center

Location: M D Anderson Cancer Center Houston Texas

Summary

The study investigates whether certain characteristics of gynecological cancer can help researchers predict how well a patient recovers from surgery to remove the lower colon, rectum, and bladder, and create openings through which urine and stool are passed out of the body (pelvic exenteration). Comparing the types of surgery completed and procedures used may help researchers to determine which are most effective and safe in patients with a history of gynecologic cancer.

Eligibility Criteria

Inclusion Criteria: * Women with a history of gynecologic malignancy, including cervical, endometrial, vulvar, or vaginal carcinoma of any histology * Women who have undergone a pelvic exenteration after January 1993 or who are being offered a pelvic exenteration for treatment of their gynecologic malignancy * Patients must be suitable candidates for surgery (in case of prospective collection) * Patients who have signed an approved informed consent * Patients with a prior malignancy allowed if \> 3 years previous with no current evidence of disease * Women must be able to read and write in either Spanish or English Exclusion Criteria: * Patients with contraindications to surgery * Patients unwilling or unable to complete self-administered questionnaires * Patients who do not read or speak English or Spanish

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT00791635). StuddyBuddy aggregates publicly available trial information.